Table 3: Adverse events in safety population for hydroxychloroquine prophylaxis randomized control trials.

 

N

Control

Hydroxychloroquine

p-value

n

Any adverse event

n

Any adverse event

Abella, et al. [19]

130

65

17

26%

65

29

45%

0.03

Rajasingham, et al. [18]

1405

469

100

21%

936

316

34%

< 0.001

Mitja, et al. [17]

2497

1300

77

6%

1197

671

56%

< 0.001

Boulware, et al. [16]

700

351

59

17%

349

140

40%

< 0.001

Rajasingham, et al. [18]: Rajasingham results are presented for pooled hydroxychloroquine arms.